Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: Insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry

American Heart Journal

Volumn 166, Issue 4, 2013, Pages 737-743

  Miller, Amy Leigh ^a   Gosch, Kensey ^b   Daugherty, Stacie L ^c   Rathore, Saif ^d   Peterson, Pamela N ^c,e   Peterson, Eric D ^f   Ho, P Michael ^c,g   Chan, Paul S ^b   Lanfear, David E ^h   Spertus, John A ^b   Wang, Tracy Y ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d YALE UNIVERSITY   (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOLOGIST; CARDIOVASCULAR MORTALITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICALLY UNINSURED; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT DISCHARGE; PRIMARY PREVENTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME; UNITED STATES;

EID: 84885149914     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.019     Document Type: Article

References (26)

1. A.E. Buxton, K.L. Lee, and J.D. Fisher A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 25 1999 1882 1890
2. Writing Committee 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
3. Writing Committee ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine Circulation 118 24 2008 2596 2648
4. S.D. Solomon, R.J. Glynn, and S. Greaves Recovery of ventricular function after myocardial infarction in the reperfusion era: the Healing and Early Afterload Reducing Therapy Study Ann Intern Med 134 6 2001 451 458
5. S.H. Hohnloser, K.H. Kuck, and P. Dorian Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 24 2004 2481 2488
6. G. Steinbeck, D. Andresen, and K. Seidl Defibrillator implantation early after myocardial infarction N Engl J Med 361 15 2009 1427 1436
7. J.T. Bigger The Coronary Artery Bypass Graft Patch Trial I. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery N Engl J Med 337 22 1997 1569 1575
8. H. Voller, W. Kamke, and H.U. Klein Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry Europace 13 4 2011 499 508
9. G. Zou A modified poisson regression approach to prospective studies with binary data Am J Epidemiol 159 7 2004 702 706
10. A.F. Hernandez, G.C. Fonarow, and L. Liang Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 13 2007 1525 1532
11. L.H. Curtis, S.M. Al-Khatib, and A.M. Shea Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death JAMA 298 13 2007 1517 1524
12. K.L. Thomas, S.M. Al-Khatib, and R.C. Kelsey Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35% Am J Cardiol 100 6 2007 924 929
13. T. Raghunathan, P. Solenberger, and J. Van Hoewyk IVEware: imputation and variance estimation software - user guide 2002 University of Michigan Ann Arbor, Michigan
14. S.D. Solomon, S. Zelenkofske, and J.J.V. McMurray Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N Engl J Med 352 25 2005 2581 2588
15. N.M. Allen LaPointe, S.M. Al-Khatib, and J.P. Piccini Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction Circ Cardiovasc Qual Outcomes 4 2 2011 146 151
16. P.M. Ho, S.A. Luther, and F.A. Masoudi Inpatient and follow-up cardiology care and mortality for acute coronary syndrome patients in the Veterans Health Administration Am Heart J 154 3 2007 489 494
17. G.M.A.F.G.C. Hernandez Af RElationship between early physician follow-up and 30-day readmission among medicare beneficiaries hospitalized for heart failure JAMA 303 17 2010 1716 1722
18. J.M. Castellanos, L.M. Smith, and P.D. Varosy Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey Heart Rhythm 9 6 2012 874 881
19. D.D. Matlock, P.N. Peterson, and P.A. Heidenreich Regional variation in the use of implantable cardioverter-defibrillators for primary prevention Circ Cardiovasc Qual Outcomes 4 1 2011 114 121
20. A.D. Staniforth, S.C. Sporton, and N.M. Robinson Is there a sex bias in implantable cardioverter-defibrillator referral and prescription? Heart 90 8 2004 937 938
21. S.L. Daugherty, P.N. Peterson, and Y. Wang Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Am Heart J 158 2 2009 224 229
22. R.H. Mehta, L. Liang, and A.M. Karve Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives JAMA 300 16 2008 1897 1903
23. L.M. Gravelin, J. Yuhas, and M. Remetz Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death Circ Cardiovasc Qual Outcomes 4 2 2011 152 156
24. B. Shah, A.F. Hernandez, and L. Liang Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry J Am Coll Cardiol 53 5 2009 416 422
25. R. Parkash, J.L. Sapp, and M. Basta Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit/clinical perspective Circ Arrhythm Electrophysiol 5 4 2012 706 713
26. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (IMPROVE HF) Circulation 122 6 2010 585 596